ZS

Many pharma companies have invested heavily in omnichannel capabilities but are still struggling to realize the full benefits. ZS’s Carolyn Morrow, Kate Sadler and Pete Mehr write about how companies can change existing processes and ways of working to develop these critical new capabilities. https://bit.ly/3XxWOzL

Key account management (KAM) remains a work in progress for pharma. Learn how Pfizer harmonized its key accounts process with help from ZS: https://bit.ly/4ge4MVN

Pharma’s CRM systems need to deliver personalized experiences, boost engagement and drive growth, but that’s unlikely without a radical rethink. ZS’s Mahmood Majeed and Srihari Sarangan share the vision for the next-gen CRM: https://bit.ly/3XfsCYC

In the ZS Medical Affairs Outlook Report 2024, Sunil John and Sarah Jarvis detail the six enablers of ZS’s next-gen medical affairs approach and how it can help organizations transform their go-to-market frameworks: https://bit.ly/3MqbkD8

This report stems from an annual survey of more than 160 medical affairs professionals from dozens of global companies and 160 key opinion leaders in the U.S., Canada and Europe.

The complex world of formulary compliance is easier to navigate with AI-powered solutions. Neelabh Saxena and Ricky Yuen explain how AI agents can revolutionize the formulary verification process, enhancing accuracy, efficiency and scalability for pharmaceutical companies: https://bit.ly/3MnSWed

Adaptation, collaboration and innovation will define hotel success as the transient tech industry evolves to serve corporate travelers and helps advance initiatives. Chart your path with insights from ZS and AHLA: https://bit.ly/4dxL2L7

Turn supply chain disruptions into opportunities for growth by building an “anti-fragile” supply chain. We share three sources of competitive advantage you can capitalize on now: https://bit.ly/3WX7iqI

We explore five generative-AI-driven use cases that can differentiate key account management (KAM) across the customer engagement process. Take these steps now to harness the power of in life sciences: https://bit.ly/46Nvsc0

We hope to see you in Boston on August 20-21 for NCODA’s 2024 Oncology Institute. ZS will be there to discuss the critical role of collaboration between life sciences, oncology practices and community-based organizations in advancing health equity. Don’t miss this opportunity to be part of the conversation and make a difference in oncology care. Register today: https://bit.ly/4d7ISSu

How do health plans manage coverage decisions with GLP-1s? Here are three payer strategies for balancing cost and access with today’s obesity drugs: https://bit.ly/3SApsNB

Medical affairs is changing at an unprecedented pace. In this new era, the function will need to deliver patient outcomes at scale. We break down what that means in this white paper: https://bit.ly/3Ab9zHm

Computational architecture has evolved as new technologies become commonplace. But virtualizing an entire pipeline requires extensive storage and is computationally expensive. In this white paper, we look at the benefits of containerization and how we can create efficiencies for bioinformatics pipelines with Nextflow: https://bit.ly/3A6lR3x

A fantastic day of networking and hands-on AI fun! For those who couldn’t join us, don’t worry. Our next stop is London on Sept. 25.

Generative AI can help unlock a daily dose of voice-of-the-customer insights. Read how companies use data to market the products consumers actually want. https://bit.ly/3Y4QaS2

If you’re leading a sales team, now is your time to preorder the “Harvard Business Review Sales Management Handbook.”

ZS’s Prabhakant Sinha, Arun Shastri and Sally Lorimer lay out hundreds of actionable ideas to manage your sales force better and drive digital success. https://bit.ly/3XXghur

In a continuing effort to focus on value of care over volume of care, Alnylam recently partnered with ZS to launch its Strategic Account Management program. The program aims to identify gaps in the patient journey to find solutions that improve patient experiences and outcomes. Read more about the impact that this partnership will make on the U.S. healthcare system: https://bit.ly/3zhkoqA

ZS is acquiring Digital Additive, a leader in data-driven marketing solutions, as we strengthen our Salesforce capabilities to deliver even more value to clients. Together, we're poised to create unparalleled experiences and insights in the digital marketing landscape. Learn how we can help you achieve success: https://bit.ly/4chvdXU

BIO International 2024 is almost over! We’ve met so many of you and made some exciting connections. If you haven’t had the chance, be sure to stop by and see us at booth 3941 and catch a live demo of ZAIDYN.

Yesterday at BIO International Convention, ZSers hosted a panel, “Future of biopharma innovation: Unleashing the potential of emerging therapeutic modalities in oncology and beyond.” Experts discussed the latest product trends, including new emerging modalities and their potential to improve patient outcomes. Learn how ZS can help you ignite innovation and growth: https://bit.ly/3X5Zh4A

Have you experienced ZAIDYN? Join us at BIO International at booth 3941 for a live demo of our cloud-native, AI-powered platform.

We’re live at BIO International 2024! Come visit us at booth 3941 and check out our hands-on demo of ZAIDYN.

BIO International 2024 is almost here. Join our ZS experts June 3-6 for the latest in biopharma innovations and get a firsthand look at ZAIDYN, our AI-powered, cloud-native platform. https://bit.ly/4bVNZ7L

Be sure to stop by our booth at BIO International, June 3-6, to experience ZAIDYN, our cloud-native platform, and discover how our AI-powered applications can boost field performance, expedite product launches and tailor customer engagement. https://bit.ly/3Vnhn0A

Join ZS’s Romain Bonnot, Malik Kaman and Parul Mahajan at BIO 2024 on June 4 for their panel, “Future of biopharma innovation: Unleashing the potential of emerging therapeutic modalities in oncology and beyond.”

They’ll discuss the latest trends in the pharma product landscape, specifically new emerging modalities that have the potential to address areas of high unmet need and improve patient outcomes. Register here: https://bit.ly/4bBfEdV